- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Head and Neck Cancer by Vaccination
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-04-23
DOI
10.3389/fimmu.2018.00830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model
- (2018) Alex Allen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4+and CD8+T cell responses
- (2018) Il-Kyu Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monitoring T cell–dendritic cell interactions in vivo by intercellular enzymatic labelling
- (2018) Giulia Pasqual et al. NATURE
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma
- (2017) Paul Zolkind et al. ORAL ONCOLOGY
- Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas
- (2017) Turunen Aaro et al. Oncotarget
- Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma
- (2017) A. N. Meleshko et al. Human Vaccines & Immunotherapeutics
- Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4
- (2017) Christopher J Hanley et al. JNCI-Journal of the National Cancer Institute
- MVX-ONCO-1 phase 1 final results of the first personalized cell-based immunotherapy using cell encapsulation technology
- (2016) N. Mach et al. ANNALS OF ONCOLOGY
- Abstract LB-095: HPV E7 antigen-expressing Listeria-based immunotherapy (ADXS11-001) prior to robotic surgery for HPV-positive oropharyngeal cancer enhances HPV-specific T cell immunity
- (2016) Rosemarie Krupar et al. CANCER RESEARCH
- Upregulated Glucose Metabolism Correlates Inversely with CD8 + T-cell Infiltration and Survival in Squamous Cell Carcinoma
- (2016) Christian H. Ottensmeier et al. CANCER RESEARCH
- HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
- (2016) Andrew G. Schache et al. CANCER RESEARCH
- The Safety and Immunological Effects of rAd5-EBV-LMP2 Vaccine in Nasopharyngeal Carcinoma Patients: A Phase I Clinical Trial and Two-Year Follow-Up
- (2016) Yongfeng Si et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes
- (2016) K. J. McCann et al. CLINICAL CANCER RESEARCH
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16 + cervical intraepithelial neoplasia 2/3 (CIN2/3)
- (2016) Ronald D. Alvarez et al. GYNECOLOGIC ONCOLOGY
- The present status and future prospects of peptide-based cancer vaccines
- (2016) Masatoshi Hirayama et al. INTERNATIONAL IMMUNOLOGY
- Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
- (2016) Laura Q.M. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
- (2016) Elisabeth Quoix et al. LANCET ONCOLOGY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
- (2016) Marij J. Welters et al. Science Translational Medicine
- HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy
- (2016) Francesca Paolini et al. Human Vaccines & Immunotherapeutics
- Carcinogenic human papillomavirus infection
- (2016) Mark Schiffman et al. Nature Reviews Disease Primers
- Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
- (2015) Aldo Venuti et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System
- (2015) Aurélien Lathuilière et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
- (2015) Cornelia L Trimble et al. LANCET
- A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence
- (2015) F. T. Zamuner et al. MOLECULAR CANCER THERAPEUTICS
- A novel “priming-boosting” strategy for immune interventions in cervical cancer
- (2015) Shujie Liao et al. MOLECULAR IMMUNOLOGY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Innate immune recognition of DNA: A recent history
- (2015) Alan Dempsey et al. VIROLOGY
- Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
- (2015) Sonia Whang et al. Viruses-Basel
- Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
- (2015) Charu Aggarwal et al. Journal for ImmunoTherapy of Cancer
- Head and Neck Cancer: Global Burden and Regional Trends in India
- (2014) Anupam Mishra et al. Asian Pacific Journal of Cancer Prevention
- Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
- (2014) P. J. Schuler et al. CLINICAL CANCER RESEARCH
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
- (2014) Y. Yoshitake et al. CLINICAL CANCER RESEARCH
- Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
- (2014) Tanguy Y. Seiwert et al. CLINICAL CANCER RESEARCH
- The role of sexual behavior in head and neck cancer: implications for prevention and therapy
- (2014) Eleni Rettig et al. Expert Review of Anticancer Therapy
- Regression of Human Papillomavirus Intraepithelial Lesions Is Induced by MVA E2 Therapeutic Vaccine
- (2014) Ricardo Rosales et al. HUMAN GENE THERAPY
- Epstein-Barr Virus and Human Papillomavirus Infections and Genotype Distribution in Head and Neck Cancers
- (2014) Zeyi Deng et al. PLoS One
- Alphavirus-Based Vaccines
- (2014) Kenneth Lundstrom Viruses-Basel
- Overexpressed oncogenic tumor-self antigens
- (2014) Robert K Bright et al. Human Vaccines & Immunotherapeutics
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- (2014) Ole Audun Werner Haabeth et al. Frontiers in Immunology
- The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
- (2013) Peggy J. de Vos van Steenwijk et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
- (2013) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo
- (2013) Shu-jie Liao et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
- (2013) Mariette I E van Poelgeest et al. Journal of Translational Medicine
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Promising systemic immunotherapies in head and neck squamous cell carcinoma
- (2013) Neil Gildener-Leapman et al. ORAL ONCOLOGY
- The Papillomavirus E2 proteins
- (2013) Alison A. McBride VIROLOGY
- Human papillomavirus oncoproteins and apoptosis (Review)
- (2013) PEIYUE JIANG et al. Experimental and Therapeutic Medicine
- Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
- (2013) Willem W Overwijk et al. Journal for ImmunoTherapy of Cancer
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
- (2012) Lindsey Chudley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dissection of T-cell Antigen Specificity in Human Melanoma
- (2012) R. S. Andersen et al. CANCER RESEARCH
- inducTION of mage-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma
- (2012) Caroline J. Voskens et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions
- (2012) Miroslaw J. Szczepanski et al. ORAL ONCOLOGY
- Whole Cell Vaccines—Past Progress and Future Strategies
- (2012) Bridget P. Keenan et al. SEMINARS IN ONCOLOGY
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
- (2012) John T. Schiller et al. VACCINE
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
- (2011) Jean-Luc Brun et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune Suppression in Head and Neck Cancers: A Review
- (2011) Anaëlle Duray et al. Clinical & Developmental Immunology
- Improvement of different vaccine delivery systems for cancer therapy
- (2011) Azam Bolhassani et al. Molecular Cancer
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
- (2011) N. Stransky et al. SCIENCE
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- Living with oral cancer: Epidemiology with particular reference to prevalence and life-style changes that influence survival
- (2010) Saman Warnakulasuriya ORAL ONCOLOGY
- Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
- (2010) M. J. P. Welters et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 1st International Workshop on Papillomavirus E5 Oncogene—A report
- (2010) Giuseppe Borzacchiello et al. VIROLOGY
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
- (2009) M. Hashibe et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
- (2009) Lindsey Low et al. HUMAN GENE THERAPY
- The role of human papillomavirus in the increased incidence of base of tongue cancer
- (2009) Per Attner et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Preexisting MAGE-A3-Specific CD4+ T Cells in Cancer Patients and Healthy Individuals and Their Activation by Protein Vaccination
- (2009) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery
- (2009) Simon R. Best et al. VACCINE
- HPV & head and neck cancer: a descriptive update
- (2009) Peter KC Goon et al. Head and Neck Optical Diagnostics Society
- Epitope Landscape in Breast and Colorectal Cancer
- (2008) N. H. Segal et al. CANCER RESEARCH
- Host responses to alphavirus infection
- (2008) Kate D. Ryman et al. IMMUNOLOGICAL REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now